Statins and secondary prevention of ischemic and hemorrhagic stroke

Stroke

Volumn 39, Issue 7, 2008, Pages

  Squizzato, Alessandro ^a   Dentali, Francesco ^a   Romualdi, Erica ^a   Ageno, Walter ^a  

^a UNIVERSITY OF INSUBRIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PRAVASTATIN;

BRAIN HEMORRHAGE; CEREBROVASCULAR ACCIDENT; CHOLESTEROL BLOOD LEVEL; DRUG EFFICACY; HUMAN; LETTER; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SECONDARY PREVENTION; STROKE; TRANSIENT ISCHEMIC ATTACK; BRAIN ISCHEMIA; CLINICAL TRIAL; METHODOLOGY; NOTE; QUALITY CONTROL; RISK FACTOR; STATISTICAL ANALYSIS;

BRAIN ISCHEMIA; CEREBRAL HEMORRHAGE; CLINICAL TRIALS AS TOPIC; DATA INTERPRETATION, STATISTICAL; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; QUALITY CONTROL; RESEARCH DESIGN; RISK FACTORS; STROKE;

EID: 47649120742     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.107.517151     Document Type: Letter

References (4)

1. Amarenco P, Bogousslavsky J, Callahan A III, Goldstein LB, Hennerici M, Rudolph AE, Sillesen H, Simunovic L, Szarek M, Welch KM, Zivin JA; Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Investigators. High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med. 2006;355:549-559.
2. Vergouwen MDI, De Haan RJ, Vermeulen M, Roos YBWEM. Statin treatment and the occurence of hemorrhagic stroke in patients with a history of cerebrovascular disease. Stroke. 2008;39:497-502.
3. Higgins JPT, Green S, eds. Cochrane handbook for systematic reviews of interventions 4.2.6 [updated September 2006]. In: The Cochrane Library. Issue 4, 2006. Chichester, UK: John Wiley & Sons, Ltd; 2006.
4. Parmar MK, Torri V, Stewart L. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med. 1998;17:2815-2834.